MORGAN STANLEY

Position in CGON — CG Oncology, Inc.

CIK 895421 NEW YORK, NY

Position in CGON

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$83,633,592

+$48,425,580 QoQ

Shares Held

1,177,109

+126.3% QoQ

Ownership

1.33%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#20

of 226 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 84% Shared 0% None 16%

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,717,848,792 across 523 Biotechnology names. CGON ranks #46 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	42,931,597	$2,407,174,637
2	VRTX	Vertex Pharmaceuticals Inc / Ma	3,242,139	$1,610,467,694
3	ROIV	Roivant Sciences Ltd.	42,592,905	$1,507,362,901
4	REGN	Regeneron Pharmaceuticals, Inc.	1,397,712	$871,529,332
5	MRNA	Moderna, Inc.	9,538,094	$667,952,718
6	ARGX	Argenx SE	643,123	$596,670,219
7	TECH	BIO-TECHNE Corp	6,374,717	$450,373,747
8	INCY	Incyte Corp	2,948,364	$334,226,536

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$83,633,592	1,177,109	+126.3%	Shares	Defined	2026-08-13
2026-03-31	$35,208,012	520,213	-4.6%	Shares	Defined	2026-05-15
2025-12-31	$22,629,185	545,019	-15.2%	Shares	Defined	2026-05-27
2025-09-30	$25,876,433	642,414	-65.6%	Shares	Defined	2026-05-27
2025-06-30	$48,571,848	1,868,148	+97.7%	Shares	Defined	2025-08-15
2025-03-31	$23,145,030	945,081	+30.3%	Shares	Defined	2025-05-15
2024-12-31	$20,799,507	725,227	+208.8%	Shares	Defined	2025-05-15
2024-09-30	$8,861,680	234,871	+148.0%	Shares	Defined	2025-05-14
2024-06-30	$2,989,959	94,709	+28.5%	Shares	Defined	2025-05-14
2024-03-31	$3,236,481	73,724	—	Shares	Defined	2024-10-17
No filing history on record for this holder in this stock.